Concentric Capital Strategies, LP Merck & Co., Inc. Transaction History
Concentric Capital Strategies, LP
- $2.07 Billion
- Q4 2024
A detailed history of Concentric Capital Strategies, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 2,596 shares of MRK stock, worth $232,342. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,596
Previous 13,123
80.22%
Holding current value
$232,342
Previous $1.49 Million
82.68%
% of portfolio
0.01%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding MRK
# of Institutions
3,952Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.8 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.23 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.48 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $227B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...